Investing.com-- Eli Lilly and Company (NYSE:LLY) said on Tuesday evening that China’s food and drug regulator had approved its Kisunla treatment for early symptomatic Alzheimer's ...
**NM signifies a non meaningful value. A dash signifies the data is not available.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback